Skin Analytics raises £15 million funding to deliver AI skin cancer detection worldwide
April 16, 2025
Skin Analytics has secured £15 million in Series B funding led by Intrepid Growth Partners.
Skin Analytics has secured £15 million in Series B funding led by Intrepid Growth Partners.
An additional nine NHS trusts have been funded to pilot Skin Analytics’ AI medical device to detect cancerous skin lesions, with around 45,000 patients benefiting from this groundbreaking technology by the summer when skin cancer referrals are at their highest.
Created to accelerate the evaluation of Artificial Intelligence (AI) technologies within the NHS, the NHSX award is highly competitive and prestigious, with an extensive evaluation process. Being granted the award is a major validation of what we do at Skin Analytics and the effort we have put in to build strong foundations based on clinical evidence, regulatory rigor and proprietary AI.